Royal Bank of Canada
ORGS

Royal Bank of Canada’s Orgenesis Inc. Common Stock ORGS Stock Holding History

Royal Bank of Canada’s Portfolio ORGS Stock Details ORGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-47
Closed – – 7650
2024
Q2 		$0 Buy
47
+37
+370% +$194 ﹤0.01% 7678
2024
Q1 		$0 Buy
+10
New +$53 ﹤0.01% 7745
2023
Q4 		– Sell
-12
Closed – – 7708
2023
Q3 		$0 Sell
12
-16
-57% -$143 ﹤0.01% 7740
2023
Q2 		$0 Buy
+28
New +$332 ﹤0.01% 7770
2022
Q4 		– Sell
-17
Closed – – 7861
2022
Q3 		$0 Buy
+17
New +$320 ﹤0.01% 7988
2021
Q3 		– Sell
-568
Closed -$29K – 7940
2021
Q2 		$29K Buy
568
+394
+226% +$19.8K ﹤0.01% 6373
2021
Q1 		$10K Buy
174
+67
+63% +$4.37K ﹤0.01% 6820
2020
Q4 		$5K Buy
107
+104
+3,467% +$5.01K ﹤0.01% 6669
2020
Q3 		$0 Buy
+3
New +$163 ﹤0.01% 7012
2020
Q2 		– Sell
-12
Closed – – 6979
2020
Q1 		$0 Hold
12
– – ﹤0.01% 7115
2019
Q4 		$1K Sell
12
-21
-64% -$700 ﹤0.01% 6706
2019
Q3 		$1K Buy
+33
New +$1.47K ﹤0.01% 6539
2018
Q4 		– Sell
-2
Closed – – 7205
2018
Q3 		$0 Buy
+2
New +$135 ﹤0.01% 7006
2018
Q2 		– Sell
-50
Closed -$5K – 6831
2018
Q1 		$5K Buy
+50
New +$5.92K ﹤0.01% 5943

Other funds holding ORGS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Royal Bank of Canada's ORGS Position: Q3 2024 in Review

Royal Bank of Canada sold out of Orgenesis Inc. Common Stock (ORGS) in Q3 2024, closing a stake of 47 shares.

Royal Bank of Canada first reported a position in ORGS in Q1 2018 and held it in 14 quarters. The position peaked at $29K in Q2 2021. 11 funds tracked by Wall St. Rank hold ORGS as of Q3 2024.

  • Royal Bank of Canada reported no remaining Orgenesis Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Royal Bank of Canada sold 47 Orgenesis Inc. Common Stock shares in Q3 2024.
  • Royal Bank of Canada first reported a position in Orgenesis Inc. Common Stock in Q1 2018 and held it in 14 quarters.
  • Royal Bank of Canada's Orgenesis Inc. Common Stock position peaked at $29K in Q2 2021.
  • 11 funds tracked by Wall St. Rank held Orgenesis Inc. Common Stock as of Q3 2024.

Based on Royal Bank of Canada's 13F filing for Q3 2024, filed 14 Nov 2024.